The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.

Respiratory Syncytial Virus (RSV) is a major pathogen causing low respiratory tract disease (bronchiolitis), primarily in infants. Helminthic infections may alter host immune responses to both helminths and to unrelated immune triggers. For example, we have previously shown that filarial cystatin (A...

Full description

Saved in:
Bibliographic Details
Main Authors: Martijn J Schuijs, Susanne Hartmann, Murray E Selkirk, Luke B Roberts, Peter J M Openshaw, Corinna Schnoeller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0161885&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232382614929408
author Martijn J Schuijs
Susanne Hartmann
Murray E Selkirk
Luke B Roberts
Peter J M Openshaw
Corinna Schnoeller
author_facet Martijn J Schuijs
Susanne Hartmann
Murray E Selkirk
Luke B Roberts
Peter J M Openshaw
Corinna Schnoeller
author_sort Martijn J Schuijs
collection DOAJ
description Respiratory Syncytial Virus (RSV) is a major pathogen causing low respiratory tract disease (bronchiolitis), primarily in infants. Helminthic infections may alter host immune responses to both helminths and to unrelated immune triggers. For example, we have previously shown that filarial cystatin (AvCystatin/Av17) ameliorates allergic airway inflammation. However, helminthic immunomodulators have so far not been tested in virus-induced disease. We now report that AvCystatin prevents Th2-based immunopathology in vaccine-enhanced RSV lung inflammation, a murine model for bronchiolitis. AvCystatin ablated eosinophil influx, reducing both weight loss and neutrophil recruitment without impairing anti-viral immune responses. AvCystatin also protected mice from excessive inflammation following primary RSV infection, significantly reducing neutrophil influx and cytokine production in the airways. Interestingly, we found that AvCystatin induced an influx of CD4+ FoxP3+ interleukin-10-producing T cells in the airway and lungs, correlating with immunoprotection, and the corresponding cells could also be induced by adoptive transfer of AvCystatin-primed F4/80+ macrophages. Thus, AvCystatin ameliorates enhanced RSV pathology without increasing susceptibility to, or persistence of, viral infection and warrants further investigation as a possible therapy for virus-induced airway disease.
format Article
id doaj-art-fe53840812094a7d825ad2a1eba1e2b2
institution OA Journals
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-fe53840812094a7d825ad2a1eba1e2b22025-08-20T02:03:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01118e016188510.1371/journal.pone.0161885The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.Martijn J SchuijsSusanne HartmannMurray E SelkirkLuke B RobertsPeter J M OpenshawCorinna SchnoellerRespiratory Syncytial Virus (RSV) is a major pathogen causing low respiratory tract disease (bronchiolitis), primarily in infants. Helminthic infections may alter host immune responses to both helminths and to unrelated immune triggers. For example, we have previously shown that filarial cystatin (AvCystatin/Av17) ameliorates allergic airway inflammation. However, helminthic immunomodulators have so far not been tested in virus-induced disease. We now report that AvCystatin prevents Th2-based immunopathology in vaccine-enhanced RSV lung inflammation, a murine model for bronchiolitis. AvCystatin ablated eosinophil influx, reducing both weight loss and neutrophil recruitment without impairing anti-viral immune responses. AvCystatin also protected mice from excessive inflammation following primary RSV infection, significantly reducing neutrophil influx and cytokine production in the airways. Interestingly, we found that AvCystatin induced an influx of CD4+ FoxP3+ interleukin-10-producing T cells in the airway and lungs, correlating with immunoprotection, and the corresponding cells could also be induced by adoptive transfer of AvCystatin-primed F4/80+ macrophages. Thus, AvCystatin ameliorates enhanced RSV pathology without increasing susceptibility to, or persistence of, viral infection and warrants further investigation as a possible therapy for virus-induced airway disease.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0161885&type=printable
spellingShingle Martijn J Schuijs
Susanne Hartmann
Murray E Selkirk
Luke B Roberts
Peter J M Openshaw
Corinna Schnoeller
The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
PLoS ONE
title The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
title_full The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
title_fullStr The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
title_full_unstemmed The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
title_short The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
title_sort helminth derived immunomodulator avcystatin reduces virus enhanced inflammation by induction of regulatory il 10 t cells
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0161885&type=printable
work_keys_str_mv AT martijnjschuijs thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT susannehartmann thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT murrayeselkirk thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT lukebroberts thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT peterjmopenshaw thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT corinnaschnoeller thehelminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT martijnjschuijs helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT susannehartmann helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT murrayeselkirk helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT lukebroberts helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT peterjmopenshaw helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells
AT corinnaschnoeller helminthderivedimmunomodulatoravcystatinreducesvirusenhancedinflammationbyinductionofregulatoryil10tcells